Life Expectancy in Dogs With Heart Disease: What Owners Need to Know

What Is the Life Expectancy for Dogs With Mitral Valve Disease?

With Fluid in the Lungs (Congestive Heart Failure – Stage C and Beyond)

When evaluating life expectancy in dogs with heart disease, it is critical to determine whether the dog has entered congestive heart failure. Heart failure means the dog currently has, or has previously had, fluid in the lungs.

Clinical studies show that once heart failure develops, the average survival time is approximately 260 days when treated with pimobendan, furosemide, and possibly ACE inhibitors and/or spironolactone. This represents an average: some dogs may live only days or weeks, while others survive more than two years.

Overall, after the onset of heart failure, a life expectancy of about 9 to 12 months is a realistic estimate for many dogs.

Without Fluid in the Lungs (Preclinical Stages B1 and B2)

If a dog has not yet developed heart failure, it may take several years before symptoms appear. At this stage, prognosis depends largely on how early the disease is diagnosed.

The most accurate assessments come from repeated cardiac ultrasounds, which allow veterinarians to monitor changes over time. A large, well-known study evaluated the effect of pimobendan (Vetmedin) in dogs with heart enlargement but no clinical signs, comparing treated dogs to a placebo group.

The results were striking. Dogs treated with pimobendan developed heart failure or experienced cardiac-related death after an average of 3.2 years, which was approximately 15 months longer than dogs that did not receive the medication. This clearly demonstrates the importance of early diagnosis and timely treatment.

If the disease is diagnosed later—such as when a dog begins coughing—a significant portion of the preclinical phase may already have passed, shortening the remaining time before heart failure.

On average:

• With pimobendan: ~3.2 years from diagnosis of heart enlargement to heart failure

• Without pimobendan: ~2 years

Life Expectancy in Dogs With Enlarged Hearts Due to Dilated Cardiomyopathy (DCM)

Large and giant breeds are more likely to develop dilated cardiomyopathy (DCM). In this disease, the heart muscle weakens and gradually loses its ability to pump blood effectively. Over time, this can lead to fluid buildup in the lungs and dangerous heart rhythm disturbances.

In the asymptomatic (preclinical) stage of DCM, pimobendan (Vetmedin) is the most important medication. A recent study in Doberman Pinschers showed that dogs treated with pimobendan lived significantly longer—an average of 623 days, compared to 466 days in untreated dogs.

Another study involving Irish Wolfhounds found that dogs receiving pimobendan survived approximately 65 months before developing heart failure or experiencing sudden cardiac death—nearly twice as long as dogs treated with other medications alone.

Clinical experience suggests that dogs with early-detected, asymptomatic DCM may remain symptom-free for 2 to 4 years. However, there is always a risk of sudden cardiac death, particularly with this disease.

Once heart failure develops, survival time is typically 6 to 12 months.

Summary: Life Expectancy in Dogs With DCM

• Asymptomatic stage: approximately 2–4 years

• After heart failure develops: typically 6–12 months

Factors That Affect Life Expectancy in Dogs With Heart Disease

Several factors can significantly influence prognosis and life expectancy:

• Other medical conditions: Diseases such as kidney failure can limit treatment options and worsen outcomes.

• Breed: Certain breeds experience faster disease progression, such as the Cavalier King Charles Spaniel with mitral valve disease.

• Medication compliance: Some dogs resist taking multiple daily medications, making optimal treatment challenging.

• Weight and muscle loss: Loss of muscle mass in advanced stages is associated with a poorer prognosis.

• Fainting episodes and sudden cardiac death: Syncope indicates a more serious condition. Dogs with DCM are especially at risk.

• Owner awareness and response: Owners who notice changes early and seek prompt veterinary care can often stabilize their dog sooner. Monitoring resting respiratory rate at home is particularly important.